Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Drug–Drug Interaction Between Dihydroartemisinin–Piperaquine and Sulfadoxine‐Pyrimethamine During Malaria Chemoprevention in Pregnant Women

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3471Source: DataRank Database

Drug–Drug Interaction Between Dihydroartemisinin–Piperaquine and Sulfadoxine‐Pyrimethamine During Malaria Chemoprevention in Pregnant Women is a research paper published in Clinical Pharmacology & Therapeutics (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.92)OA: bronzeTopics (59)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Michelle E. Roh ORCID,Yourong Z. Geng,Leonard Opio,Bishop Opira,Florence Marzan

Live enrichment

PubMed:39402742 PMC:PMC11747899 OpenAlex:https://openalex.org/W4403440597

NIAID NIH HHS

Grant: U01 AI141308

NIAID NIH HHS

Grant: R01 AI117001

NICHD NIH HHS

Grant: K99 HD111572

FWCI

2.92

Citation Percentile

0.9%

Citation Trend

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3471

BRONZEhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3471

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3471

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.3471

journalhttps://doi.org/10.1002/cpt.3471

Fields of Study

Malaria Research and ControlDrug Transport and Resistance MechanismsPharmacological Effects and Toxicity StudiesMedicineAdolescentAdultFemaleHumansPregnancyYoung AdultAntimalarialsArtemisininsDrug CombinationsDrug InteractionsDrug Therapy, CombinationMalariaPregnancy Complications, ParasiticPyrimethamineQuinolinesSulfadoxineUgandaPiperazines

MeSH Terms

AdolescentAdultAntimalarialsDrug CombinationsDrug InteractionsDrug Therapy, CombinationFemaleHumansMalariaPiperazinesPregnancyPyrimethamineQuinolinesSulfadoxineUgandaPregnancy Complications, ParasiticArtemisininsYoung Adult

Keywords

PiperaquineMedicinePharmacokineticsSulfadoxine/pyrimethamineAdverse effectSulfadoxineDihydroartemisininDosingGestational agePharmacologyPyrimethamineMalariaPregnancyInternal medicineArtemisininChloroquinePlasmodium falciparumImmunologyBiology

Sustainable Development Goals

SDG 0: Good health and well-being